Skip to main content
Premium Trial:

Request an Annual Quote

French DNA Data Storage Startup Biomemory Raises €5M in Seed Funding

NEW YORK – French DNA synthesis and data storage company Biomemory has received €5 million in seed funding, one of the firm's lead investors said on Monday.

The round was led by investment company Eurekare and the French Tech Seed Fund, managed by Bpifrance, with the support of Paris Business Angels, Prunay Impact, and existing investors.

Founded in 2021, Paris-based Biomemory is developing a "petrol-free DNA synthesis and copy process based on synthetic biology," Eurekare said in a statement. With the funds raised, the company will optimize the technology while reducing its costs.

Eurekare said Biomemory currently has the potential to reduce the cost of DNA synthesis to $1 per megabyte, and, through further optimization, the method can achieve $1 per terabyte.

To accomplish this cost reduction, Biomemory will focus on miniaturization, automation, and parallelization of an end-to-end integrated and continuous microfluidic DNA assembly device.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.